MEETINGS - Conference and exhibition on Emerging Medical Technologies Europe (Netherlands) April 1999:
This article was originally published in Clinica
Medical Data International will hold a conference and exhibition entitled Emerging Medical Technologies Europe in Amsterdam on April 19-20. The meeting will include keynote speeches on how to increase your market share in a changing European market and a look at the future of the worldwide medical device industry. For further details contact MDI in the US. Tel: +1 949 251 2780. Fax: +1 949 955 6353.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.